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Objectives: To evaluate the ability of manganese perovskite nanoparticles (lanthanum-strontium manganite) to heat the tumor tis-
sue in vivo under action of external alternating magnetic field. Materials and Methods: The magnetic fluid on the basis of nanopar-
ticles of perovskite manganite was tested in the heating experiments using of alternating magnetic field of frequency 300 kHz and 
amplitude 7.7 kA/m. Guerin carcinoma was transplanted into the muscle of rat. Magnetic fluid was injected intramuscularly 
or intratumorally. Temperature was measured by copper-constantan thermocouple. Results: Temperature of magnetic fluid was 
increased by 56 °C for 10 min of alternating magnetic field action. Administration of magnetic fluid into the muscle followed by al-
ternating magnetic field resulted in the elevation of muscle temperature by 8 °C after 30 min post injection. Temperature of the 
tumor injected with magnetic fluid and treated by alternating magnetic field was increased by 13.6 °C on the 30 min of combined 
influence. Conclusion: In vivo study with rat tissue has demonstrated that magnetic fluid of manganite perovskite injected in the 
tumor increases the tumor temperature under an alternating magnetic field. Obtained results emphasize that magnetic fluid of man-
ganite perovskite can be considered as effective inducer of tumor hyperthermia.
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In the previous publication it was shown the pos-
sibility of synthesized magnetic fluid based on lantha-
num-strontium manganite nanoparticles to generate 
the heat in externally applied alternating magnetic field 
(AMF) in vitro as well as lack of side effects of magnetic 
fluid administered into both non-tumor and tumor-
bearing mice and rats [1]. The proposition to use the 
nanoparticles of perovskite manganite in the tumor 
hyperthermia is based on the postulate that these 
nanoparticles are able to demonstrate the ferromag-
netic effect in the range of x=0.25–0.5 with Curie point 
= 0–95 �C that allows to avoid the overheating of sur-
rounding normal tissues [2–7]. Samples of proposed 
nanocomposites were received in some laboratories, 
and their ability to be heated in the AMF in the system 
in vitro was shown [8–14].
It has to be noted that mentioned publications have 
shown the ability of nanoparticles of perovskite man-
ganite to be heated by AMF action in model experiment 
[4, 8, 10, 13–14] and only one study presented theo-
retical calculations of the possibility of effective auto-
stabilization of the temperature in the vicinity of T �C= 
42 �C for nanoparticles of perovskite manganite [7]. 
Unfortunately, studies which could demonstrate the 
possibility to heat the tumor tissue with nanoparticles 
of perovskite manganite combined with AMF have not 
to be found in the accessible literature.
Taking into account this circumstance the current 
study was aimed to evaluate the ability of nanopar-
ticles of perovskite manganite, in particular in the 
form of magnetic fluid under action of external AMF, 
to heat the biological tissues, especially tumor in the 
system in vivo.
MATERIALS AND METHODS
Magnetic fluid. Magnetic fluid based on the 
synthesized nanoparticles of perovskite manganite 
(La1-xSrxMnO3) and water solution of agarose, has been 
used in current study. Characteristics of magnetic fluid 
were presented earlier [1].
Alternating magnetic field. The rat leg was treat-
ed by external AMF after injection into muscle or in-
tramuscularly transplanted tumor (Guerin carcinoma). 
A high frequency generator worked out by Institute 
of Electrodynamics was used to induce an alternat-
ing current of 7.7 kA at a frequency of 300 kHz [1]. 
The current passes through a custom-made five-turn 
water-cooled coil of 30 mm in internal diameter and 
30 mm in height to generate a magnetic field inside 
the coil.
Temperature measurement. Tumor temperature 
during heating was measured by means of cooper-
constantan thermocouples (0.1 mm diameter; IF-Kyiv). 
The thermocouples were calibrated against a certified 
precision mercury-in-glass thermometer (Committee 
of State Standards, Ukraine) before and after each 
experiment. Temperature was recorded always with 
the power switched off.
Animal and tumor models. All studies were con-
ducted with strain IEPOR bread rats (Institute of Experi-
mental Pathology, Oncology and Radiobiology, NAS 
of Ukraine, Kyiv, Ukraine) weighting 150–200 g and 
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bearing Guerin carcinoma transplanted intramuscu-
larly into the right flank. The principle and method 
of transplantation were conventional. Animal were 
kept in Makrolon cages bedded with dust-free wood 
granulate, and had free access to a standard diet and 
tap water. All experiments had been approved by the 
regional animal ethics committee.
All 35 female rats were taken into experiment 
7–9 days after transplantation (tumor volume 
1.0–1.5 cm3), anaesthetized with “calipsovet plus” 
at a dose of 0.1 ml/100g b.w., i.p. before the onset 
of experiment. Each animal was placed into a special 
prepared net-hammock suspended to make free leg. 
The net-hammock was fixed on the tripod so that the 
femur of animal was localized in the water-cooled mag-
netic induction coil with diameter of 3.0 cm (Fig. 1). 
Suspension of magnetic fluid of manganite perovskite 
was administered into the muscle (5 rats) or tumor 
(30 rats) at a dose of 0.5–0.6 ml (50 mg manganite 
per ml). Tissue temperature was measured when 
generator was switched off to avoid the influence 
of alternating magnetic field.
Fig. 1. Photograph of rat in the special created net-hammock 
(the femur is located in the coil of magnetic field generator)
In experiments in vitro temperature was measured 
every 5 min under the switched off generator but 
in experiments in vivo such procedure was repeated 
not so often to avoid the living tissue damage (every 
15–20 min, in average).
RESULTS AND DISCUSSION
It was shown earlier that synthesized nanoparticles 
of lanthanum-strontium manganite did not display the 
toxicity or provoked the side effects in experimental 
animals with transplanted tumors [1].
At the first step of current study it was examined 
the ability of magnetic fluid of manganite perovskite 
to be heated in model experiment. Magnetic fluid was 
taken at a volume of 1.5 ml into the plastic tube which 
was located then in the coil of the generator of AMF 
in such way the tube setting up in the center of the 
field configuration. During the experiment temperature 
of magnetic fluid was measured when the generator 
was switched off. Obtained results were presented 
in Fig. 2. It was registered the increase of magnetic 
fluid temperature up to 72–75 �С within 10 min of AMF 
action. Fig. 3 represents the plot of temperature versus 
time after the onset of AMF action, and clearly dem-
onstrates the increase of magnetic fluid temperature 
in comparison with the initial one. It has to be noted 
that specimens of magnetic fluid synthesized in diffe-
rent periods of time and used in this study displayed 
almost the same changes of temperature under AMF 
in experiment in vitro (Fig. 4).
0 5 10 15 20
10
20
30
40
50
60
70
80
t, 
°C
min
Fig. 2. Magnetic heating of manganite perovskite magnetic fluid 
under applied AMF (300 kHz, 7.7 kA/m). Ordinate — temperature 
(Т �С), abscisse — duration of AMF action (min)
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Fig. 3. Plot of temperature (t/t0) versus time of the magnetic 
heating of manganite perovskite magnetic fluid under applied 
AMF (300 kHz, 7.7 kA/m). Ordinate — temperature (t/t0), ab-
scisse — duration of AMF action (min)
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Fig. 4 Magnetic heating of manganite perovskite magnetic fluid 
under applied AMF (300 kHz, 7.7 kA/m). Specimens of magnetic 
fluid synthesized in the different period of study were examined. 
Ordinate — temperature (Т �С), abscisse — duration of AMF 
action (min)
At the second step it was provided the experiments 
in vivo. The heating of magnetic fluid was evaluated 
after it was injected into the muscle of intact animal 
leg or into the tumor in the femur as well as into the 
muscle of opposite leg of tumor-bearing rats. It was 
determined that the temperature of femur muscle 
of intact rat (magnetic fluid was administered into 
the muscle) was increased by 8 �С within 20–30 min 
of AMF action (Fig. 5). The temperature of tumor (ad-
ministration into the tumor, Guerin carcinoma) was 
increased by 8.3 �С within 10 min, by 10.8 �С within 
20 min, by 13.6 �С within 30 min of AMF (Fig. 6, 7). 
These results have distinctly shown that magnetic fluid 
on the basis of lanthanum-strontium manganite is able 
to increase the tumor temperature, i.e., “to heat” 
the tumor under influence of external AMF and can 
be considered as an effective inductor of tumor local 
hyperthermia.
0 10 20 30 40
32
34
36
38
40
42
44
46
48
min
t, 
°C
Fig. 5. Magnetic heating of rat muscle after intramuscular ad-
ministration of manganite perovskite magnetic fluid under ap-
plied AMF (300 kHz, 7.7 kA/m). Ordinate — temperature (T �С), 
abscisse — duration of AMF action (min)
Obtained results are the first demonstration of the 
possibility to heat the tumor up to therapeutically 
relevant temperature, i.e., 43–44 0 with nanoparticles 
of manganite perovskite in the system in vivo. The 
temperature in muscle tissue surrounding the tumor 
node was not increased over 37–39 �C indicating the 
minimal possibility of the normal tissue overheating 
(Fig. 8). This observation confirms the idea about the 
self-controlled heating by exploitation of manganite 
substances [4, 12].
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Fig. 6. Magnetic heating of Guerin carcinoma after intratumoral 
administration of manganite perovskite magnetic fluid under 
applied AMF (300 kHz, 7.7 kA/m). It is given individual curves 
of rat tumor heating; experiment on 13.12.11: 1 and 2 — Guerin 
carcinoma was transplanted into both femurs of the same rat. 
Оrdinate — temperature (T �С), abscisse — duration of AMF 
action (min)
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Fig. 7. Plot of temperature (t/t0) versus time of the magnetic 
heating of Guerin carcinoma after intratumoral administration 
of manganite perovskite magnetic fluid under applied AMF 
(300 kHz, 7.7 kA/m). It is given individual curves of rat tumor 
heating. Оrdinate — temperature (t/t0), abscisse — duration 
of AMF (min)
It should to be also noted that the analysis of ob-
tained results has indicated that there is necessity 
to discuss the problems of coating, agglomeration 
of nanoparticles as well as their size that may influence 
the efficacy of heating, the distribution of nanopar-
ticles in the tumor tissue as well as the manifestation 
of their magnetic properties in the specific tumor 
microenvironment.
The therapeutic relevance of nanohyperthermia 
method using manganite perovskite magnetic fluid and 
external AMF as single mean as well as in combination 
with chemotherapy is under evaluation now in ex-
periment with transplanted tumors in vivo. Moreover, 
the advantage of nanohyperthermia in comparison 
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with conventional radiofrequency hyperthermia has 
to be assessed obligatory, as we suppose.
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Fig. 8. Plot of temperature (t/t0) versus time of the magnetic 
heating of muscle and Guerin carcinoma after intramuscular 
or intratumoral administration of manganite perovskite magnetic 
fluid under applied AMF (300 kHz, 7.7 kA/m). Ordinate — tem-
perature (t/t0), abscisse — duration of AMF action (min)
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